Inovio to present poster on INO-3107 at ASCO annual meeting

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

INO

0.00
  • Inovio to present preclinical hemophilia A gene-transfer data at American Society of Gene and Cell Therapy annual meeting in Boston on May 12.
  • Clinical immune-response data for INO-3107 in recurrent respiratory papillomatosis set for poster presentation at American Society of Clinical Oncology annual meeting in Chicago on May 30.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605080805PR_NEWS_USPR_____PH54543) on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.